ICER publishes final evidence report and policy recommendations on roxadustat

5 March 2021 - Independent appraisal committee determines the evidence is not adequate to demonstrate that roxadustat provides a net ...

Read more →

PBAC Public Summary Documents - November 2020 meeting

5 March 2021 - The Public Summary Documents (positive recommendations and subsequent decisions not to recommend) from the November 2020 PBAC ...

Read more →

Create a U.S. Institute of Health Technology Assessment to preserve innovation and control costs

2 March 2021 - The public outcry to “do something” about health care spending keeps growing, but fear about what that ...

Read more →

Ofev (nintedanib) receives positive recommendation from CADTH and INESSS for the treatment of progressive fibrosing interstitial lung diseases

4 March 2021 - Ofev is the first treatment available in Canada for chronic fibrosing interstitial lung diseases with a progressive ...

Read more →

The PHARMAC non-review?

4 March 2021 - The recently announced PHARMAC review is fatally flawed.  ...

Read more →

NICE rejects rare blood cancer treatment Poteligeo in final appraisal

4 March 2021 - The UK’s NICE has not recommended Kyowa Kirin’s Poteligeo for the treatment of adults living with ...

Read more →

Cancer patient told palliative care only option after being rejected PHARMAC funding

2 March 2021 - The drug-buying agency was placed under an independent review today after the Prime Minister said she ...

Read more →

PHARMAC ripe for reassessment

3 March 2021 - New Zealand’s drug buying agency PHARMAC has long been, simultaneously, a good thing in itself and ...

Read more →

NICE backs NHS use of Lilly’s Olumiant in eczema

3 March 2021 - Eli Lilly’s Olumiant has received a UK NICE recommendation for the treatment of moderate-to-severe atopic dermatitis ...

Read more →

What could Biden’s possible bid for a national health technology assessment entity look like?

2 March 2021 - The U.S. has never had a publicly funded, independent health technology assessment organisation to evaluate prescription drugs, ...

Read more →

ICER publishes Final Evidence Report and policy recommendations on new therapies for high cholesterol

2 March 2021 - For bempedoic acid, independent appraisal committee votes that the evidence is not adequate to demonstrate a net ...

Read more →

Government announces review into PHARMAC

2 March 2021 - The Government is following through on an election promise to conduct an independent review into PHARMAC, ...

Read more →

Medicines New Zealand supportive of Government’s PHARMAC review assuming it is not a box-ticking exercise

2 March 2021 - Medicines New Zealand is supportive of the proposed review into PHARMAC if it is intended to improve ...

Read more →

Review asks how Government can get the new drugs it wants funded

2 March 2021 - The much-vaunted PHARMAC inquiry, being announced today, will investigate how the drug-buying agency can be brought ...

Read more →

Nusinersen in spinal muscular atrophy: indication of considerable added benefit in children with an early onset of the disease

1 March 2021 - The treatment delays permanent ventilation of the children and extends life. In addition, the children develop more ...

Read more →